Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts Journal Article

Local Library Link: Find It @ Loyola

Authors: Molvar, C.; Lewandowski, R.
Article Title: Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts
Abstract: Hepatocellular carcinoma (HCC) is a lethal tumor, claiming over half a million lives per year. Treatment of HCC is commonly performed without curative intent, and palliative options dominate, including catheter-based therapies, namely, transarterial chemoembolization and yttrium-90 ((90)Y) radioembolization. This review will showcase the performance of (90)Y radioembolization for the treatment of HCC, focusing on recent seminal data and technical advances. In particular, novel radioembolization treatment concepts are discussed and compared with conventional HCC therapy.
Journal Title: Seminars in interventional radiology
Volume: 32
Issue: 4
ISSN: 0739-9529; 0739-9529
Publisher: Unknown  
Journal Place: United States
Date Published: 2015
Start Page: 388
End Page: 397
Language: eng
DOI/URL:

10.1055/s-0035-1564704
Notes: LR: 20151214; JID: 8510974; OID: NLM: PMC4640917 [Available on 12/01/16]; OTO: NOTNLM; PMCR: 2016/12/01 00:00; ppublish